OPTIMA Supporting Catalent with New High-Speed Vial Filling Line for COVID-19 Vaccine Program

OP_Filling and closing for vaccines_1
A high-performance filling line, like this one is currently being customized for delivery to Catalent. The filling line components are currently being assembled quickly and safely within Optima’s new CSPE Center. (Source: Optima)
Fast track delivery of a complete filling solution under isolator

Optima Group welcomes Catalent’s recent announcement that it has signed an agreement with a major global pharmaceutical company to accelerate availability of manufacturing capacity and prepare for large-scale commercial manufacturing of a lead vaccine candidate for COVID-19 at Catalent’s facility in Bloomington, Indiana. Scale-up in production will include the use of an Optima high-speed vial filling line.

"Our employees are working rapidly to bring the completed vial line to Catalent’s biologics site in the United States. We are very pleased to be able to contribute to overcoming the coronavirus pandemic and to support Catalent in increasing its production capacities," says Gerhard Breu, Chairman of the Optima Pharma Division.
Further information on special machine solutions for the fight against COVID-19 is available at:  www.optima-packaging.com/fightcovid-19

Pharmaceutical filling machine
A wide variety of process steps are required for the filling of vaccines – from washing and sterilizing the vials to filling and closing. All system components are tested and accepted as part of the CSPE approach at Optima in Schwaebisch Hall. (Source: Optima)
Press release
Text and Image (.ZIP, 3.31 MB)
Denise Fiedler and Julia Völker
Do you have any questions? Please feel free to contact us.
Denise Fiedler and Julia Völker
Team Group Communication
+49 791 506-1472 pr-group@optima-packaging.comWrite e-mail
Denise Fiedler and Julia Völker
Denise Fiedler and Julia Völker
Team Group Communication
© 2024 OPTIMA. All rights reserved.
loading ...